Skip to main content

Advertisement

SpringerLink
Log in

Do we need alternative treatment options for autoimmune hepatitis?

  • Invited Commentary
  • Published:
Current Gastroenterology Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Manns MP, Strassburg CP: Autoimmune hepatitis: clinical challenges. Gastroenterology 2001, 120:1502–1517.

    Article  PubMed  CAS  Google Scholar 

  2. Czaja AJ, Freese DK: Diagnosis and treatment of autoimmune hepatitis. AASLD Practice Guideline. Hepatology 2002, 36:479–495.

    Article  PubMed  Google Scholar 

  3. Cook GC, Mulligan R, Sherlock S: Controlled prospective trial of corticosteroid therapy in active chronic hepatitis. Q J Med 1971, 40:159–185.

    PubMed  CAS  Google Scholar 

  4. Soloway RD, Summerskill WHJ, Baggenstoss AH, et al.: Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis. Gastroenterology 1972, 63:820–833.

    PubMed  CAS  Google Scholar 

  5. Murray-Lyon IM, Stern RB, Williams R: Controlled trial of prednisone and azathioprine in active chronic hepatitis. Lancet 1973, i:735–737.

    Article  Google Scholar 

  6. Roberts SK, Therneau T, Czaja AJ: Prognosis of histological cirrhosis in type 1 autoimmune hepatitis. Gastroenterology 1996, 110:848–857.

    Article  PubMed  CAS  Google Scholar 

  7. Vierling JM, Flores PA: Evolving new therapies of autoimmune hepatitis. Clin Liver Dis 2002, 6:825–850.

    PubMed  Google Scholar 

  8. Czaja AJ: Treatment of autoimmune hepatitis. Semin Liver Dis 2002, 22:365–377.

    Article  PubMed  CAS  Google Scholar 

  9. Czaja AJ, Bianchi FB, Carpenter HA, et al.: Treatment challenges and investigational opportunities in autoimmune hepatitis. Hepatology 2005, 41:207–215.

    Article  PubMed  Google Scholar 

  10. Summerskill WHJ, Korman MG, Ammon HV, et al.: Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared. Gut 1975, 16:876–883.

    PubMed  CAS  Google Scholar 

  11. Alvarez F, Ciocca M, Canero-Velasco C, et al.: Short-term cyclosporine induces a remission of autoimmune hepatitis in children. J Hepatol 1999, 30:222–227.

    Article  PubMed  CAS  Google Scholar 

  12. Richardson PD, James PD, Ryder SD: Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis patients resistant to or intolerant of azathioprine. J Hepatol 2000, 33:371–375.

    Article  PubMed  CAS  Google Scholar 

  13. Danielsson A, Prytz H: Oral budesonide for treatment of autoimmune chronic active hepatitis. Aliment Pharmacol Ther 1994, 8:585–590.

    Article  PubMed  CAS  Google Scholar 

  14. Czaja AJ, Lindor KD: Failure of budesonide in a pilot study of treatment-dependent autoimmune hepatitis. Gastroenterology 2000, 119:1312–1316.

    Article  PubMed  CAS  Google Scholar 

  15. Csepregi A, Roecken CH, Treiber G, Malfertheiner P: Budesonide induces complete remission in autoimmune hepatitis. World J Gastroenterol 2006, 12:1362–1366.

    PubMed  CAS  Google Scholar 

  16. Nakamura K, Yoneda M, Yokohama S, et al.: Efficacy of ursodeoxycholic acid in Japanese patients with type 1 autoimmune hepatitis. J Gastroenterol Hepatol 1998, 13:490–495.

    PubMed  CAS  Google Scholar 

  17. Crosignani A, Battezzati PM, Setchell KDR, et al.: Effects of ursodeoxycholic acid on serum liver enzymes and bile acid metabolism in chronic active hepatitis: a doseresponse study. Hepatology 1991, 13:339–344.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Gastroenterology, Hepatology, and Infectious Diseases, Otto-von-Guericke University, Magdeburg, Leipziger Strasse 44, D-39120, Magdeburg, Germany

    Peter Malfertheiner MD

Authors
  1. Antal Csepregi MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peter Malfertheiner MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Peter Malfertheiner MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Csepregi, A., Malfertheiner, P. Do we need alternative treatment options for autoimmune hepatitis?. Curr Gastroenterol Rep 8, 177–178 (2006). https://doi.org/10.1007/s11894-006-0069-6

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11894-006-0069-6

Keywords

Search

Navigation